Cite

HARVARD Citation

    Popat, S. et al. (2020). Anti-angiogenic agents in the age of resistance to immune checkpoint inhibitors: Do they have a role in non-oncogene-addicted non-small cell lung cancer?. Lung cancer. pp. 76-84. [Online]. 
  
Back to record